Centers for Disease Control and Prevention (CDC)

FLC Region

Security Lab



1600 Clifton Road NE
Atlanta, GA 30329
United States

Want more information? Contact a representative below.

Laboratory Representative


CDC works 24/7 to protect the health, safety, and security of Americans. CDC fights disease whether it starts at home or abroad, is infectious or not, or occurs naturally, by accident, or from a deliberate attack. CDC promotes the health and well-being of Americans of all ages—doing all it can to prevent infections, injuries, and illnesses from ever occurring.

CDC protects the nation and the world by:

  • Detecting, responding to, and stopping new and emerging health threats.
  • Preventing injuries, illnesses, and premature deaths.
  • Discovering new ways to protect and improve the public's health through science and advanced technology.

With an annual budget of more than $12 billion and more than 13,000 staff, CDC supports communities throughout the U.S. and protects Americans by working in more than 60 countries around the world. Almost 85% of CDC's domestic funding is provided directly to state and local entities to detect and control disease, prevent the leading causes of death, and prepare for health threats.


CDC works 24/7( to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.

CDC increases the health security of our nation. As the nation’s health protection agency, CDC saves lives and protects people from health threats. To accomplish our mission, CDC conducts critical science and provides health information that protects our nation against expensive and dangerous health threats, and responds when these arise.

Technology Disciplines

Displaying 51 - 60 of 157
Immunogenic Hepatitis E Virus Polypeptides for Vaccine and Diagnostics Development
Immunogenic Hepatitis E Virus Polypeptides for Vaccine and Diagnostics Development
Improved Acoustic Plethysmograph System for Noninvasive Measurement of Pulmonary Function
Improved Botulism, Botulinum Neurotoxin Type-E Diagnostics
Improved Protein Quantification Process and Vaccine Quality Control Production
Improved simian HIV (SHIV) prevention in non-human primate models with chemoprophylaxis combination that can be taken in one or two oral doses before or after exposure
Inexpensive, Personal Dust Detector Tube/Dosimeter Operating on a Gas Detector Tube Platform
Influenza A Virus Detection and Subtyping Directly from Animal Swabs and Environmental Samples
Intranasal Dry Powder Inhaler for Improved Delivery of Vaccines and Therapeutics


Displaying 1 - 10 of 12
Anthropometry Scanning Laboratory
High Bay Laboratory
Human Digital Modeling & Hand Scanning Lab
Human Factors Laboratory
NIOSH Lake Lynn Laboratory
NIOSH Mobile Emergency Medical Service (EMS) Work Environment Laboratory
NIOSH Pittsburgh Research Laboratory
NIOSH Spokane Research Laboratory
Protective Systems Laboratory
Safety Engineering Laboratory



No Equipment


CDC's Office of Financial Resources awards and administers grants and cooperative agreements to state and local governments, foreign ministries and associations, domestic non-profits/educational institutions, and domestic for-profit groups. Individuals are ineligible to apply for and cannot receive funding through CDC grants and/or cooperative agreements.

Grants and cooperative agreements provide the means to transfer money, technical assistance, and expertise to partners in exchange for their contributions to federal public health goals and objectives. " Assistance"s or "financial assistance mechanisms" are terms used to refer to grantsand cooperative agreements collectively, although they have different meanings.


The Small Business Innovation Research (SBIR) program is a set-aside program (3.2% of an agency’s extramural budget in FY2019) for domestic small business concerns to engage in Research/Research and Development (R/R&D) that has the potential for commercialization and public benefit. The SBIR program was established under the Small Business Innovation Development Act of 1982 (P.L. 97-219).

The Small Business Innovation Research (SBIR) Program provides “seed funds” for small business concerns (SBCs) to explore their technological potential and the incentive for SBCs to profit from commercialization of their innovations. The CDC’s SBIR Program targets innovations in diagnostics, surveillance, and public health to support the health promotion and disease prevention needs of the CDC.

CDC’s SBIR program is under the stewardship of CDC’s Office of Science, Office of Technology and Innovation (OTI). This office is committed to ensuring a competitive award process that results in projects of scientific excellence and technological innovation with the potential for commercialization.

About the SBIR Program

The Small Business Innovation Research (SBIR) Program, encourages small business to engage in research and development (R&D) that has the potential for commercialization. The program’s specific objectives are to:
•Use small businesses to stimulate technological innovation
•Strengthen the role of small business in meeting Federal R/R&D needs
•Increase private-sector commercialization of innovations derived from Federal research and development funding
•Increase small business participation in Federal R/R&D
•Foster and encourage participation by socially and economically disadvantaged small business concerns and women-owned business concerns in the SBIR program

Eligible Institutions/Organizations:

Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A SBC is one that, on the date of award for both Phase I and Phase II funding agreements, meets ALL of the criteria as described in the current SBIR parent funding opportunity announcement available at the NIH Small Business Funding Opportunities website. See

Please direct all inquiries to: Office of Technology and Innovation,, 404-718-1386.

Work collaboratively with state and community partners to efficiently and effectively implement chronic disease prevention and health promotion strategies.

For more than 20 years, CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) has provided low-income, uninsured, and underserved women access to timely breast and cervical cancer screening and diagnostic services.

Comprehensive cancer control (CCC) is a collaborative and strategic approach used by communities and their partners to combine, share, and coordinate resources to reduce the burden of cancer. In 1998, CDC established the National Comprehensive Cancer Control Program (NCCCP) to support this wide-ranging and inclusive effort. The program provides funding and technical support for the development and implementation of CCC plans. These plans guide the work of many and focus on current and emerging cancer issues, including cancer prevention, early detection, treatment, rehabilitation, and survivorship. Today, CDC funds CCC programs in all 50 states, the District of Columbia, seven tribes and tribal organizations, and seven U.S. territories.

Data collected by local cancer registries enable public health professionals to understand and address the cancer burden more effectively. CDC provides support for states and territories to maintain registries that provide high-quality data.


No Publications


No News


No Successes


No Licenses